about
Xa inhibitors for acute coronary syndromesIncidence and causes of heparin-induced skin lesionsFondaparinux sodium in the prophylaxis and treatment of deep vein thrombosis and pulmonary embolism.Nadroparin carries a potentially high risk of inducing cutaneous delayed-type hypersensitivity responses.Anticoagulation with the oral direct thrombin inhibitor dabigatran does not enlarge hematoma volume in experimental intracerebral hemorrhage.Antiplatelet and antithrombin strategies in acute coronary syndrome: state-of-the-art review.Anticoagulation via anti-Factor Xa inhibition.Delayed-type heparin allergy: diagnostic procedures and treatment alternatives-a case series including 15 patients.Blood coagulation factor Xa as an emerging drug target.The risk for cross-reactions after a cutaneous delayed-type hypersensitivity reaction to heparin preparations is independent of their molecular weight: a systematic review.Use of Molecular Dynamics for the Refinement of an Electrostatic Model for the In Silico Design of a Polymer Antidote for the Anticoagulant Fondaparinux.Simple and rapid quality control of sulfated glycans by a fluorescence sensor assay--exemplarily developed for the sulfated polysaccharides from red algae Delesseria sanguinea.Pharmacological profiles of animal- and nonanimal-derived sulfated polysaccharides--comparison of unfractionated heparin, the semisynthetic glucan sulfate PS3, and the sulfated polysaccharide fraction isolated from Delesseria sanguinea.
P2860
Q24243766-69364026-4B38-4AF7-8587-3C48BF5A427AQ33386398-8B23DA7F-13AA-4B49-8C21-2BB8BFCED2EDQ33389966-9CBD25E9-D7FA-40B0-B1E4-821EF1E6E558Q33440138-2C311DEE-8613-4ED7-A6A3-41D09372B906Q34017336-304E1176-9CF7-49DB-B2E6-D2B937387636Q36302146-FF234D17-B4A6-479F-B62D-6324CF346E3BQ36458159-ECAF7E8A-F425-4DD4-A7BC-EC81165F24E8Q36834381-A323974F-73E9-423D-B3D1-A89E66B7D4E5Q37830708-BE84AC94-0D03-48AE-BCA6-0B67B8C752D2Q37883468-5B4EFDE2-A983-4378-9EA9-1E1DBB2DB0E5Q38840652-A808CE51-13AB-4120-BCDF-FF6FE6900AACQ39317791-F98AEB03-9F3A-4E03-B6E0-FCDD68F76AF7Q43171467-80FBFEBB-DF9E-4017-9C81-1696EB053236
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
From heparins to factor Xa inhibitors and beyond.
@ast
From heparins to factor Xa inhibitors and beyond.
@en
type
label
From heparins to factor Xa inhibitors and beyond.
@ast
From heparins to factor Xa inhibitors and beyond.
@en
prefLabel
From heparins to factor Xa inhibitors and beyond.
@ast
From heparins to factor Xa inhibitors and beyond.
@en
P2860
P1476
From heparins to factor Xa inhibitors and beyond.
@en
P2093
P2860
P356
10.1111/J.0960-135X.2005.01452.X
P478
35 Suppl 1
P577
2005-03-01T00:00:00Z